Sanara Ventures
- Company typePrivate
- Founded2015
- HeadquartersRa'anana, Israel
- Headcount1–10
- GTM typeB2B
- OfferingServices
Sanara Ventures firmographics
Firmographics- Name
- Sanara Ventures
- Legal name
- Sanara Capital
- Website
- https://sanaraventures.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Sanara Ventures industry classification
Industry- Product category
- Venture Capital / Healthcare Investment
- NAICS
- Portfolio Management and Investment Advice (523940), Funds, Trusts, and Other Financial Vehicles (525), Other Investment Pools and Funds (5259)
- SIC
- Investment Advice (6282), Finance Services (6199)
- akta.pro primary industry
- Early-Stage Venture Capital (Series A/B) (FSANAAAB)
- akta.pro secondary industry
- Corporate Strategic Partnership & Ecosystem Investment Arms (FSANAHAF)
Keywords
Where Sanara Ventures is headquartered
LocationHeadquarters
- HQ city
- Ra'anana
- HQ country
- Israel
- HQ region
- Middle East
Offices1 record
Markets served
Sanara Ventures business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Venture Capital Fund Management: Returns generated from portfolio company exits, including IPOs, acquisitions, and secondary transactions. Sanara Capital generates returns through successful exits of investments in Digital Health, Bio-Convergence, and Medical Devices companies.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Sanara Ventures product offering
Product offeringCore offering
Sanara Ventures is a seed-stage venture capital investment platform established in 2015 and backed by Philips and Teva, focusing on Israeli-related healthcare startups in Digital Health, Bio-Convergence, and Medical Devices. Its follow-on fund, Sanara Capital (established 2023), specializes in A and B financing rounds. Together, the funds provide 360-degree support and value creation to nearly 20 active portfolio companies through capital deployment, strategic guidance, industry connections, and operational assistance.
Product overview
Sanara is a venture capital investment platform consisting of two distinct fund products: Sanara Ventures (seed-stage platform established in 2015) and Sanara Capital (A-B financing round fund established in 2023). Together, they provide 360-degree support and value creation to portfolio companies through a core team, venture partners, and a global advisory board of over 120 experts. The funds focus on Digital Health, Bio-Convergence, and Medical Devices sectors, with a diversified portfolio of nearly 20 active companies in both funds.
Differentiator
Problem solved
Functional benefit
Products and services
- Sanara Ventures Seed-Stage Investment Platform
- Sanara Capital A-B Financing Fund
Companies that use Sanara Ventures
Customer profileSegments1 record
Ideal customer profiles1 record
Sanara Ventures technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Sanara Ventures partnerships and signals
Strategic signalScale indicators3 records
Recent moves7 records
Expansion highlights5 records
Sanara Ventures competitors and assessment
Company assessmentDirect peers
- Accelmed Ventures: Israel-focused medical device and healthtech VC investing in early-stage companies — overlapping thesis in medical devices and digital health with comparable stage focus.
- Triventures: Israel-based early-to-growth stage medtech and digital health VC investing in global healthcare startups — directly comparable to Sanara in stage, vertical focus, and Israeli roots.
- aMoon Fund: Israeli healthtech and biotech venture fund investing across early and growth stages in digital health, bio-convergence, and medical devices — the closest direct peer to Sanara given overlapping thesis, geography, and stage focus.
- 10D (Ten Dimensions) Venture Capital: Israel-based seed-to-A healthtech and digital health fund investing in Israeli startups — directly comparable to Sanara Ventures' seed-stage mandate and thesis.
- Medison Ventures: Israel-based corporate-affiliated venture arm backing early-stage healthtech and biotech startups — comparable to Sanara in stage, geography, and the leverage of strategic parent backing.
- NGT3 Ventures: Israel-based early-stage fund focused on medical device and life science technologies — directly comparable to Sanara's medical device sub-thesis and seed-to-A stage focus; notably referenced in Sanara CFO Eli Yered's background as a recent advisory role.
- Pitango Health Ventures: Israeli early-to-growth stage venture firm with dedicated healthtech and biotech investing — comparable stage, Israeli focus, and sector thesis to Sanara's two fund vehicles.
Broad incumbents
- JVP (Jerusalem Venture Partners): Long-standing Israeli VC with significant healthcare and digital health exposure across seed-to-growth stages — broader portfolio but comparable Israeli-focused early-stage healthtech activity.
- OrbiMed Israel: Global healthcare-dedicated investment firm with Israeli deal flow across medtech, biotech, and digital health — broader AUM scale but overlaps in Israeli healthtech investing, making it a broad incumbent peer.
- Sequoia Capital Israel: Global tier-1 VC with a strong Israeli healthtech practice led by Sanara venture partner Yoav Shaked (2012–present); overlaps with Sanara's Israeli healthtech investment universe but at materially larger fund scale.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Sanara Ventures social profiles
Digital presenceSanara Ventures financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sanara Ventures leadership team
Management profileNumber of profiles
Profiles12 records
Sanara Ventures funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sanara Ventures M&A and investment
M&A and investmentM&A
Investments9 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sanara Ventures
What does Sanara Ventures do?
Sanara Ventures is a seed-stage venture capital investment platform established in 2015 and backed by Philips and Teva, focusing on Israeli-related healthcare startups in Digital Health, Bio-Convergence, and Medical Devices. Its follow-on fund, Sanara Capital (established 2023), specializes in A and B financing rounds. Together, the funds provide 360-degree support and value creation to nearly 20 active portfolio companies through capital deployment, strategic guidance, industry connections, and operational assistance.
Is Sanara Ventures a public or private company?
Sanara Ventures is a private company. It is classified as venture growth investor backed and is currently operating.
When was Sanara Ventures founded?
Sanara Ventures was founded in 2015. It employs 1 to 10 people.
Where is Sanara Ventures based?
Sanara Ventures is headquartered in Ra'anana, Israel, in the Middle East region.
How does Sanara Ventures make money?
One revenue line is on record: venture Capital Fund Management.
Who are Sanara Ventures's main competitors?
Direct peers on record are Accelmed Ventures, Triventures, aMoon Fund, 10D (Ten Dimensions) Venture Capital, Medison Ventures, NGT3 Ventures and Pitango Health Ventures. Broad incumbents are JVP (Jerusalem Venture Partners), OrbiMed Israel and Sequoia Capital Israel.
Does Sanara Ventures have an API?
No public API is recorded for Sanara Ventures.
What industry is Sanara Ventures in?
Sanara Ventures's product category is Venture Capital / Healthcare Investment. Its primary akta.pro industry code is FSANAAAB, Early-Stage Venture Capital (Series A/B), with a secondary code of FSANAHAF, Corporate Strategic Partnership & Ecosystem Investment Arms. Its NAICS code is 523940 and its SIC code is 6282.